leveraging microfluidics, automation and machine learning
the future of medicine
harnessing the power of cells
We accelerate discovery and translation of cell therapies, to improve quality of life through regenerative medicine.
Regenerating damaged organs, tissues, and cells.
Leveraging the immune system to fight cancer.
Our Cell Therapy Discovery Engine
relieving R&D bottlenecks and simplifying manufacturing pipelines
Our Discovery Engine provides an unprecedented window into cell-driven biology.
Microfluidic-enabled technology allows inputs to be combinatorially multiplexed to generate tens of thousands of experimental conditions in parallel.
End-to-end assay automation, enabled by cloud-directed robotics increases experimental reproducibility, performance whilst reducing human intervention.
Multi-dimensional, single-cell resolution data is rapidly turned into actionable results or cycled back through the process for enhanced optimization.
Powering both partner and internal programs
Our Discovery Engine is enabling leading biotech and pharmaceutical companies to develop novel and optimal cell-based products and processes, simplifying manufacturing, reducing time to market, and improving clinical outcomes.
Our internal, CIRM-funded program focuses on developing clinical grade iPSC-derived dopaminergic neurons as a curative cell therapy for the more than 10 million patients suffering from Parkinson’s disease.
defining new stem cell differentiation strategies operational
June 29, 2017We're excited to announce that CIRM, California's stem cell agency, awarded us with a 2-year, ~$700k DISC-02 discovery grant. Together with collaborators at The Scripps Research Institute, we will deploy our technology to produce optimized, clinical grade manufacturing processes for dopaminergic neuron cells with the goal of treating patients with Parkinson's disease.Learn More